Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Addressing the conversation about risks and side effects of vaccination
November 17, 2015
By: Ben Locwin
Contributing Editor, Contract Pharma
When I do epidemiological work, one signal that stands out within the population data is the presence of anti-vaccination pockets within society. The so-called ‘anti-vaxxers’ present an incalculable threat to communities by avoiding the standard armamentarium of vaccines in the guidelines. Where Thinking Goes Wrong – The Behavioral Economics of Choice Vaccines can only get so safe and effective. Their actual value in society is manifested by how many people actually show up to get immunized. Former Surgeon General of the United States C. Everett Koop opined, “Drugs don’t work in patients who don’t take them.” The more I’ve been called to review cases of under-vaccination and its effects in certain areas, the more it’s driven me to realize that orthopraxis development and trials of safe and effective vaccines are only part of the equation. The other part is to not let it be ok for casual conversation to spread around about the risks and side effects of proper vaccination. To not address these when we hear them is equivalent to tacitly endorsing the myths. Every choice that we make has a spectrum of risks and benefits, and economically-speaking, we make choices that improve our status (money, health, etc.); After all, if I said to you as you were getting onto a plane for your flight that sitting in your seat (29E) could either have a payout of $0 as alternative A, or $20 as alternative B, most respondents would of course choose alternative B. Why? Because the effort and risk required and incumbent upon you are equivalent, but the payout improves by $20 to choose B over A. So, yes, as with every medical intervention, there are side effects, such as injection site redness or soreness, but at least in the case with the injectable flu vaccine you cannot get the flu from the flu shot. This is one of the many apocryphal social myths, which continues to circulate almost unimpeded. So, scientifically and ethically, it’s not ok to allow opinions and mis-truths to go unchallenged when the outcome is that certain numbers of those telling the tales or listening to them may opt to avoid immunization and increase the general risk in the community. A large part of the problem is the incredible inadequacy of people to perceive and properly evaluate and weight different risks. It’s hard to appraise what hasn’t happened to you yet in the context of something with a minor alternative risk your risk of actually becoming infected versus your perception of guaranteed side effects at the moment. So even though during an infection with the flu everyone I’ve asked has said that any vaccine side effect would be preferable to the illness, at the time of a preventive office visit it is very difficult to prognosticate the probabilities of being sick and accurately imagining the range of physiological symptoms. Likewise, virtually no one, including those who work in healthcare settings, properly understands the complicated multifactor effects of how accurate the antigen selection was for the current flu season, how many people it takes to elicit herd immunity in a region, the likelihood of infectivity from someone who is ill, and how the whole matrix of probabilities interplay to make certain areas resistant or susceptible. A Multifactorial Problem Must Be Addressed Multifactorially A recent push in Christiana Care Health Systems’ efforts to immunize their hospital staff has had a very high degree of success: The average seasonal influenza immunization rate for healthcare workers is about 65%; and this is in stark opposition to the Centers for Disease Control and Prevention recommendations that every healthcare worker should be immunized. At Christiana Care Health Systems, their current immunization rate is 93% for this year’s flu vaccine—almost a 30% increase (42% relative increase) above the healthcare average. They have achieved this rate by very visible marketing approaches and having pre-loaded syringes ready so that groundless refusals such as the time it takes, or not having the syringe prepared are rendered irrelevant. CDC data indicate that between about 5,000 and 45,000 people die in the United States alone each year due to influenza. Vaccines continue to be the most effective healthcare intervention ever developed by humans. We need to ensure that we do our part to not only ensure they are designed, developed, and manufactured properly, but also to dispel myths in the public that short-circuit vaccination’s ability to work through herd immunity, ensuring that there are so many people immunized in the population that preventable diseases don’t have unbroken vectors to spread through to cause outbreaks.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !